Acutus Medical, Inc. AFIB
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 181.20% | 57.13% | 7.01% | -31.43% | -56.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 181.20% | 57.13% | 7.01% | -31.43% | -56.21% |
| Cost of Revenue | 86.70% | 12.14% | -21.97% | -52.39% | -65.37% |
| Gross Profit | 132.50% | 97.05% | 74.69% | 79.27% | 76.68% |
| SG&A Expenses | -28.86% | -27.03% | -48.81% | -61.59% | -67.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.14% | -24.35% | -48.49% | -64.76% | -71.85% |
| Operating Income | 55.59% | 52.70% | 63.26% | 71.88% | 74.88% |
| Income Before Tax | 63.39% | -209.59% | 54.07% | -168.32% | 68.60% |
| Income Tax Expenses | -- | -23.17% | -23.17% | -23.17% | -23.17% |
| Earnings from Continuing Operations | 63.58% | -212.86% | 53.89% | -164.27% | 68.51% |
| Earnings from Discontinued Operations | 92.77% | 2.23% | -65.07% | -371.27% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 88.31% | -27.80% | -23.91% | -320.81% | -106.14% |
| EBIT | 55.59% | 52.70% | 63.26% | 71.88% | 74.88% |
| EBITDA | 56.10% | 50.46% | 61.15% | 70.33% | 73.35% |
| EPS Basic | 88.56% | -27.22% | -21.69% | -283.53% | -98.74% |
| Normalized Basic EPS | 36.36% | 46.94% | 61.30% | 69.74% | 76.58% |
| EPS Diluted | 88.56% | -14.46% | -11.65% | -217.20% | -81.91% |
| Normalized Diluted EPS | 36.36% | 40.41% | 58.22% | 68.19% | 75.69% |
| Average Basic Shares Outstanding | 2.24% | 2.58% | 2.92% | 2.96% | 2.72% |
| Average Diluted Shares Outstanding | 2.24% | -4.65% | -4.39% | -4.40% | -4.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |